Search

Your search keyword '"Foster, F."' showing total 2,895 results
Start Over Author "Foster, F."

Refine your results

2,895 results on '"Foster, F."'

1. QAnon Propaganda on Twitter as Information Warfare: Influencers, Networks, and Narratives

Author

Dilley, L., Welna, W., and Foster, F.

Subjects
Computer Science - Social and Information Networks
Abstract

QAnon refers to a set of far-right, conspiratorial ideologies that have risen in popularity in the U.S. since their initial promotion in 2017 on the 4chan internet message board. A central narrative element of QAnon is that a powerful group of elite, liberal members of the Democratic Party engage in morally reprehensible practices, but that former U.S. President Donald J. Trump was prosecuting them. Five studies investigated the influence and network connectivity of accounts promoting QAnon on Twitter from August, 2020 through January, 2021. Selection of Twitter accounts emphasized on-line influencers and "persons of interest" known or suspected of participation in QAnon propaganda promotion activities. Evidence of large-scale coordination among accounts promoting QAnon was observed, demonstrating rigorous, quantitative evidence of "astroturfing" in QAnon propaganda promotion on Twitter, as opposed to strictly "grassroots" activities of citizens acting independently. Further, evidence was obtained supporting that networks of extreme far-right adherents engaged in organized QAnon propaganda promotion, as revealed by network overlap among accounts promoting far-right extremist (e.g., anti-Semitic) content and insurrectionist themes; New Age, occult, and "esoteric" themes; and internet puzzle games like Cicada 3301 and other "alternate reality games." Based on well-grounded theories and findings from the social sciences, it is argued that QAnon propaganda on Twitter in the months circa the 2020 U.S. Presidential election likely reflected joint participation of multiple actors, including nation-states like Russia, in innovative misuse of social media toward undermining democratic processes by promoting "magical" thinking, ostracism of Democrats and liberals, and salience of White extinction narratives common among otherwise ideologically diverse groups on the extreme far-right., Comment: 60 pages, 14 figures

Published
2022

3. In memoriam: R. Mark Henkelman, 1946–2024.

Author

Nieman, Brian J., Cahill, Lindsay S., Sled, John G., Lerch, Jason P., Stanisz, Greg J., Constable, R. Todd, and Foster, F. Stuart

Subjects
MEDICAL genetics, SCIENTIFIC method, X-ray imaging, MAGNETIZATION transfer, MEDICAL physics
Abstract

The obituary in "Magnetic Resonance in Medicine" commemorates the life and contributions of R. Mark Henkelman, a distinguished Canadian biophysics researcher known for his pioneering work in MRI. Mark's career spanned from developing MRI techniques to founding the Mouse Imaging Centre at SickKids, leaving a lasting impact on imaging in medicine and science. His legacy includes advancements in MRI image artifacts, quantitative techniques, magnetization transfer, high-throughput phenotyping, and mouse model characterization, influencing current research and clinical practices. Mark's dedication to scientific innovation and mentorship continues to inspire future scientists. [Extracted from the article]

Published
2025
Full Text
View/download PDF

9. Search for neutral Higgs bosons decaying into four taus at LEP2

Author

ALEPH Collaboration, Schael, S., Barate, R., Brunelière, R., De Bonis, I., Decamp, D., Goy, C., Jézéquel, S., Lees, J. -P., Martin, F., Merle, E., Minard, M. -N., Pietrzyk, B., Bravo, B. Trocmé S., Casado, M. P., Chmeissani, M., Crespo, J. M., Fernandez, E., Fernandez-Bosman, M., Garrido, Ll., Martinez, M., Pacheco, A., Ruiz, H., Colaleo, A., Creanza, D., De Filippis, N., de Palma, M., Iaselli, G., Maggi, G., Maggi, M., Nuzzo, S., Ranieri, A., Raso, G., Ruggieri, F., Selvaggi, G., Silvestris, L., Tempesta, P., Tricomi, A., Huang, G. Zito X., Lin, J., Ouyang, Q., Wang, T., Xie, Y., Xu, R., Xue, S., Zhang, J., Zhang, L., Zhao, W., Abbaneo, D., Barklow, T., Buchmüller, O., Cattaneo, M., Clerbaux, B., Drevermann, H., Forty, R. W., Frank, M., Gianotti, F., Hansen, J. B., Harvey, J., Hutchcroft, D. E., Janot, P., Jost, B., Kado, M., Mato, P., Moutoussi, A., Ranjard, F., Rolandi, L., Schlatter, D., Teubert, F., Valassi, A., Monteil, I. Videau S., Pallin, D., Pascolo, J. M., Perret, P., Hansen, J. D., Hansen, J. R., Hansen, P. H., Kraan, A. C., Kyriakis, B. S. Nilsson A., Markou, C., Simopoulou, E., Vayaki, A., Blondel, K. Zachariadou A., Brient, J. -C., Machefert, F., Rougé, A., Videau, H., Ciulli, V., Focardi, E., Parrini, G., Antonelli, A., Antonelli, M., Bencivenni, G., Bossi, F., Capon, G., Cerutti, F., Chiarella, V., Laurelli, P., Mannocchi, G., Murtas, G. P., Passalacqua, L., Kennedy, J., Lynch, J. G., Negus, P., O'Shea, V., Thompson, A. S., Cavanaugh, R., Dhamotharan, S., Geweniger, C., Hanke, P., Hepp, V., Kluge, E. E., Putzer, A., Stenzel, H., Tittel, K., Wunsch, M., Beuselinck, R., Cameron, W., Davies, G., Dornan, P. J., Girone, M., Marinelli, N., Nowell, J., Rutherford, S. A., Sedgbeer, J. K., Thompson, J. C., White, R., Ghete, V. M., Girtler, P., Kneringer, E., Kuhn, D., Rudolph, G., Bouhova-Thacker, E., Bowdery, C. K., Clarke, D. P., Ellis, G., Finch, A. J., Foster, F., Hughes, G., Jones, R. W. L., Pearson, M. R., Robertson, N. A., Sloan, T., Smizanska, M., van der Aa, O., Delaere, C., Leibenguth, G., Blumenschein, V. Lemaitre U., Hölldorfer, F., Jakobs, K., Kayser, F., Müller, A. -S., Renk, B., Sander, H. -G., Schmeling, S., Wachsmuth, H., Zeitnitz, C., Bonissent, T. Ziegler A., Coyle, P., Curtil, C., Ealet, A., Fouchez, D., Payre, P., Tilquin, A., Ragusa, F., David, A., Dietl, H., Ganis, G., Hüttmann, K., Lütjens, G., Moser, W. Männer H. -G., Settles, R., Villegas, M., Wolf, G., Beacham, J., Yavin, K. Cranmer I., Boucrot, J., Callot, O., Davier, M., Duflot, L., Grivaz, J. -F., Heusse, Ph., Jacholkowska, A., Serin, L., Veille, J. -J., Azzurri, P., Bagliesi, G., Boccali, T., Foà, L., Giammanco, A., Giassi, A., Ligabue, F., Messineo, A., Palla, F., Sanguinetti, G., Sciabà, A., Sguazzoni, G., Spagnolo, P., Tenchini, R., Venturi, A., Awunor, P. G. Verdini O., Blair, G. A., Cowan, G., Garcia-Bellido, A., Green, M. G., Medcalf, T., Misiejuk, A., Strong, J. A., Teixeira-Dias, P., Clifft, R. W., Edgecock, T. R., Norton, P. R., Tomalin, I. R., Bloch-Devaux, J. J. Ward B., Boumediene, D., Colas, P., Fabbro, B., Lançon, E., Lemaire, M. -C., Locci, E., Perez, P., Rander, J., Tuchming, B., Vallage, B., Litke, A. M., Taylor, G., Booth, C. N., Cartwright, S., Combley, F., Hodgson, P. N., Lehto, M., Thompson, L. F., Böhrer, A., Brandt, S., Grupen, C., Hess, J., Ngac, A., Borean, G. Prange C., Giannini, G., He, H., Putz, J., Rothberg, J., Armstrong, S. R., Berkelman, K., Ferguson, D. P. S., Gao, Y., González, S., Hayes, O. J., Hu, H., Jin, S., Kile, J., McNamara III, P. A., Nielsen, J., Pan, Y. B., von Wimmersperg-Toeller, J. H., Wiedenmann, W., Wu, J., Wu, Sau Lan, Wu, X., Zobernig, G., and Dissertori, G.

Subjects
High Energy Physics - Experiment, High Energy Physics - Phenomenology
Abstract

A search for the production and non-standard decay of a Higgs boson, h, into four taus through intermediate pseudoscalars, a, is conducted on 683 pb-1 of data collected by the ALEPH experiment at centre-of-mass energies from 183 to 209 GeV. No excess of events above background is observed, and exclusion limits are placed on the combined production cross section times branching ratio, \xi^2 = \sigma(e+e- --> Zh)/\sigma_{SM}(e+e- --> Zh) x B(h --> aa)x B(a --> \tau^+\tau^-)^2. For mh < 107 GeV/c2 and 4 < ma < 10 GeV/c2, \xi^2 > 1 is excluded at the 95% confidence level., Comment: 18 pages, 16 figures

Published
2010
Full Text
View/download PDF

12. Biogenic gas nanostructures as ultrasonic molecular reporters

Author

Shapiro, Mikhail G, Goodwill, Patrick W, Neogy, Arkosnato, Yin, Melissa, Foster, F Stuart, Schaffer, David V, and Conolly, Steven M

Subjects
Physical Sciences, Engineering, Nanotechnology, Biomedical Imaging, Bioengineering, Generic health relevance, Biosensing Techniques, Contrast Media, Gases, Nanoparticles, Ultrasonography, Nanoscience & Nanotechnology
Abstract

Ultrasound is among the most widely used non-invasive imaging modalities in biomedicine, but plays a surprisingly small role in molecular imaging due to a lack of suitable molecular reporters on the nanoscale. Here, we introduce a new class of reporters for ultrasound based on genetically encoded gas nanostructures from microorganisms, including bacteria and archaea. Gas vesicles are gas-filled protein-shelled compartments with typical widths of 45-250 nm and lengths of 100-600 nm that exclude water and are permeable to gas. We show that gas vesicles produce stable ultrasound contrast that is readily detected in vitro and in vivo, that their genetically encoded physical properties enable multiple modes of imaging, and that contrast enhancement through aggregation permits their use as molecular biosensors.

Published
2014

14. Contributors

Author

Aime, Silvio, primary, Amirshaghaghi, Ahmad, additional, Angel, Peggi M., additional, Ardenkjaer-Larsen, Jan H., additional, Atreya, Raja, additional, Awe, Sunny, additional, Badea, Cristian T., additional, Beekman, Freek J., additional, Biade, Siham, additional, Borden, Mark A., additional, Brunsing, Ryan L., additional, Chandrasekharan, Prashant, additional, Chang, Jae-Byum, additional, Chen, Fei, additional, Chen, John W., additional, Chen, Xiaogyuan, additional, Cheng, Zhen, additional, Cheng, Zhiliang, additional, Cherin, Emmanuel, additional, Clinthorne, Neal H., additional, Cohen, Jonathan, additional, Colson, Caylin, additional, Conolly, Steven, additional, Contag, Christopher H., additional, Cutler, Cathy S., additional, Dayton, Paul A., additional, Devoogdt, Nick, additional, Dina, Olayinka, additional, Drake, Richard R., additional, Dubsky, Stephen, additional, Ducongé, Frédéric, additional, Fellows, Benjamin D., additional, Foster, F. Stuart, additional, Francis, Kevin P., additional, Fung, Barry K.L., additional, Gambhir, Sanjiv Sam, additional, Gao, Ruixuan, additional, Giovenzana, Giovanni B., additional, Goodwill, Patrick, additional, Goorden, Marlies C., additional, Gorpas, Dimitris, additional, Grimm, Jan, additional, Groll, Andrew N., additional, Hargus, Sally, additional, Harmsen, Stefan, additional, He, Shuqing, additional, Hensley, Daniel, additional, Hutton, Brian F., additional, Huynh, Quincy, additional, Iagaru, Andrei, additional, Josephson, Lee, additional, Jurisson, Silvia S., additional, Keselman, Paul, additional, Kircher, Moritz F., additional, Kokate, Tushar, additional, Konkle, Justin, additional, Korsen, Joshua A., additional, Krasniqi, Ahmet, additional, Laniyonu, Adebayo, additional, Levin, Craig S., additional, Lewis, Michael R., additional, Lewis, Jason S., additional, Liu, Guanshu, additional, Liu, Yajing, additional, Looger, Loren L., additional, Lu, Kuan, additional, Lu, Yao, additional, Lucignani, Giovanni, additional, Lyons, Scott K., additional, Maina, Theodosia, additional, Martelli, Cristina, additional, Matheson, Alexander M., additional, Mempel, Thorsten R., additional, Meng, Ling-Jian, additional, Moradi, Farshad, additional, Nagle, Veronica L., additional, Neurath, Markus F., additional, Nicolson, Fay, additional, Nie, Liming, additional, Ntziachristos, Vasilis, additional, Orendorff, Ryan, additional, Ottobrini, Luisa, additional, Ouyang, Yanli, additional, Paez Segala, Maria G., additional, Parraga, Grace, additional, Perez-Liva, Mailyn, additional, Pratt, Edwin C., additional, Rao, Jianghong, additional, Rath, Timo, additional, Rodriguez, Elisenda, additional, Rosenthal, Eben L., additional, Ross, Brian D., additional, Saayujya, Chinmoy, additional, Saritas, Emine Ulku, additional, Scott, Danielle A., additional, Sheth, Vipul R., additional, Slagle, Connor, additional, Tamura, Ryo, additional, Tavitian, Bertrand, additional, Tay, Zhi Wei, additional, Terreno, Enzo, additional, Thakur, Mathew, additional, Thompson, Caleb, additional, Tian, Jie, additional, Travagin, Fabio, additional, Tsourkas, Andrew, additional, Tully, Kathryn M., additional, Usmani, Shariq M., additional, VanBrocklin, Henry F., additional, van Keulen, Stan, additional, van Zijl, Peter C.M., additional, Walmer, Rachel W., additional, Wang, Cuihua, additional, Wang, Joanna, additional, Wang, Lihong V., additional, Xavier, Catarina, additional, Yao, Junjie, additional, Yu, Elaine Y., additional, Zheng, Xianchuang, additional, Zheng, Bo, additional, and Zhou, Xinyi Y., additional

Published
2021
Full Text
View/download PDF

31. Supplementary Figure Legends 1-2 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

32. Data from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 1 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Video 3 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Video 4 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Video 2 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure 2 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Video 1 from Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Author

Francia, Giulio, primary, Shaked, Yuval, primary, Hashimoto, Kae, primary, Sun, John, primary, Yin, Melissa, primary, Cesta, Carolyn, primary, Xu, Ping, primary, Man, Shan, primary, Hackl, Christina, primary, Stewart, Julie, primary, Uhlik, Mark, primary, Dantzig, Anne H., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

40. Substrate analogue studies on cephalosporin biosynthesis enzymes

Author

Foster, F and Schofield, C

Subjects
Chemistry, Organic, Enzymology, Biochemistry
Abstract

The application of β-lactams as chemotherapeutic agents in the 1940s fundamentally changed the course of medicine. Some 80 years later, β-lactam antibiotics still have a central role in modern medicine. The biosynthesis of β-lactams is arguably as remarkable as their applications. The research described in this thesis focussed on the first two steps in the biosynthesis of cephalosporins from penicillin N; the ring-expansion of penicillin N to deacetoxycephalosporin C (DAOC) and the subsequent 3’-hydroxylation of DAOC to deacetylcephalosporin C (DAC). These two steps are catalysed by a single enzyme (DAOCS/DACS) in eukaryotic fungi (A. chrysogenum), and by two distinct enzymes (DAOCS and DACS) in prokaryotes (S. clavuligerus). These three enzymes are notable both from mechanistic and medicinal perspectives. Chapter 2 describes updated expression protocols for the production of recombinant DAOCS/DACS; the DAOCS/DACS gene (cefEF) has historically proved recalcitrant to soluble expression in E. coli. Through the application of modern recombinant expression techniques, such as codon-optimisation and the use of a pCold-derived expression vector, highly active DAOCS/DACS was afforded in pleasing yield and purity. DAOCS/DACS was found to be active under simplified assay conditions compared with previous studies, and was stable after several freeze-thaw cycles. These modified expression conditions for cefEF provided a resilient stock of DAOCS/DACS with which mechanistic inquiries could be directed. Procedures for producing recombinant DAOCS and DACS were also developed. Chapter 3 describes investigations into the hydroxylase activity of DAOCS/DACS using the 3-vinyl cephem substrate analogue. Incubations of the 3-vinyl cephem with DAOCS/DACS produced a diol under standard assay conditions. When the incubations were carried out with addition of 5 mM sodium azide, the product was a cephem hydroxy azide which was isolated by HPLC and robustly characterised by LC-MS and NMR. It is proposed that azide insertion is catalysed by DAOCS/DACS, in which case this would be the first reported enzyme-catalysed incorporation of the azide functional group into the cephalosporin scaffold. DACS was also shown to catalyse the azidation reaction. Derivatisation of the azide functional group may be a route to new cephalosporin antibiotics. More generally, DAOCS/DACS-catalysed azidation suggests that the ability of 2OG oxygenases to catalyse azidation is more widespread than previously thought; the insertion of the azide group into other 2OG oxygenase substrates (e.g., lipids and proteins) should be investigated. In Chapter 4, attempts to crystallise DAOCS/DACS, as well as a mutant of DAOCS (ICM DAOCS) are described. A new co-crystallisation method, coupled with seeding experiments, produced encouraging crystalline precipitates with DAOCS/DACS and ICM DAOCS. Further optimisation is required to yield macrocrystals capable of diffraction. This work provides a foundation for the structural characterisation of DAOCS/DACS, DAOCS, and DACS. Investigations into the 3’-hydroxylation of DAOC to DAC by 18O-labelling experiments are also described in Chapter 4. The results confirm previous observations of incorporation of oxygen from water as well as from O2 into the hydroxyl group of DAC. By contrast, conversion of the 3-vinyl cephem analogue to give the hydroxy azide products proceeds without incorporation of water derived oxygen; in the case of the diol, one oxygen comes from water and one from O2. Overall, as described in Chapter 5, the work furthers the mechanistic understanding of the hydroxylase activities of DAOCS/DACS and DACS. The results imply they catalyse oxidative transformations by at least two distinct mechanisms, depending on the structure of substrate being converted. It is hypothesised that a HO−Fe(IV)=O species, with the hydroxyl ligand derived from a water molecule, could account for the observed partial incorporation of oxygen from water into some, but not all products. Such an intermediate may be involved in catalysis in other 2OG oxygenases, including those involved in clavam biosynthesis and certain human oxygenases.

Published
2023

47. Data from Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer

Author

Pham, Elizabeth, primary, Yin, Melissa, primary, Peters, Christian G., primary, Lee, Christina R., primary, Brown, Donna, primary, Xu, Ping, primary, Man, Shan, primary, Jayaraman, Lata, primary, Rohde, Ellen, primary, Chow, Annabelle, primary, Lazarus, Douglas, primary, Eliasof, Scott, primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

48. Supplemental Figures S1-S6 from Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer

Author

Pham, Elizabeth, primary, Yin, Melissa, primary, Peters, Christian G., primary, Lee, Christina R., primary, Brown, Donna, primary, Xu, Ping, primary, Man, Shan, primary, Jayaraman, Lata, primary, Rohde, Ellen, primary, Chow, Annabelle, primary, Lazarus, Douglas, primary, Eliasof, Scott, primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

49. Supplemental Methods from Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer

Author

Pham, Elizabeth, primary, Yin, Melissa, primary, Peters, Christian G., primary, Lee, Christina R., primary, Brown, Donna, primary, Xu, Ping, primary, Man, Shan, primary, Jayaraman, Lata, primary, Rohde, Ellen, primary, Chow, Annabelle, primary, Lazarus, Douglas, primary, Eliasof, Scott, primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

50. Supplementary Video 1a from Targeted Anti–Vascular Endothelial Growth Factor Receptor-2 Therapy Leads to Short-term and Long-term Impairment of Vascular Function and Increase in Tumor Hypoxia

Author

Franco, Marcela, primary, Man, Shan, primary, Chen, Limor, primary, Emmenegger, Urban, primary, Shaked, Yuval, primary, Cheung, Alison M., primary, Brown, Allison S., primary, Hicklin, Daniel J., primary, Foster, F. Stuart, primary, and Kerbel, Robert S., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results